Recombinant Mouse Defb14 Protein，His

Defb14 is a member of the beta-defensin family, which consists of small cationic peptides known for their role in the innate immune response. Research on Defb14 has gained attention due to its antimicrobial properties, particularly against a variety of pathogens, including bacteria and fungi. Discovered primarily in human and mouse tissues, Defb14 is believed to be crucial in the first line of defense, acting by disrupting microbial cell membranes and modulating inflammatory responses. Studies have suggested that Defb14 also plays a role in wound healing and tissue repair, enhancing its significance in both health and disease contexts. Its expression can be influenced by several factors, such as infections, cytokines, and environmental stimuli, making it a target of interest in understanding host-pathogen interactions and immune system regulation. The potential therapeutic applications of Defb14 in treating infections and improving immune responses have propelled ongoing research, focusing on its biochemical properties, structural analysis, and mechanisms of action. By utilizing recombinant protein technology, researchers are investigating the functional characteristics of Defb14, which could lead to the development of novel antimicrobial peptides with clinical relevance. Overall, studying Defb14 and its recombinant forms could provide valuable insights into enhancing immune response and developing new strategies to combat antibiotic-resistant infections.